Victory Capital Management Inc. Has $58.94 Million Holdings in Encompass Health Corporation $EHC

Victory Capital Management Inc. trimmed its position in Encompass Health Corporation (NYSE:EHC) by 6.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 464,049 shares of the company’s stock after selling 31,127 shares during the quarter. Victory Capital Management Inc.’s holdings in Encompass Health were worth $58,944,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank bought a new stake in Encompass Health in the 2nd quarter valued at $139,536,000. 8 Knots Management LLC acquired a new stake in shares of Encompass Health in the second quarter valued at approximately $78,644,000. Thrivent Financial for Lutherans raised its position in shares of Encompass Health by 57.8% during the third quarter. Thrivent Financial for Lutherans now owns 1,194,859 shares of the company’s stock worth $151,544,000 after acquiring an additional 437,464 shares during the last quarter. Marshall Wace LLP bought a new position in Encompass Health in the second quarter valued at about $34,719,000. Finally, Raymond James Financial Inc. grew its position in shares of Encompass Health by 31.5% during the 2nd quarter. Raymond James Financial Inc. now owns 1,143,642 shares of the company’s stock worth $140,245,000 after buying an additional 274,142 shares during the period. 97.25% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

EHC has been the topic of a number of recent analyst reports. Barclays raised their target price on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Finally, Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $143.29.

Encompass Health Stock Down 0.7%

Shares of NYSE:EHC opened at $106.89 on Friday. Encompass Health Corporation has a 52-week low of $92.53 and a 52-week high of $127.99. The company has a market capitalization of $10.63 billion, a PE ratio of 19.29, a price-to-earnings-growth ratio of 2.06 and a beta of 0.71. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08. The company has a fifty day moving average of $103.93 and a 200-day moving average of $113.71.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The business had revenue of $3.09 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same quarter in the previous year, the company posted $1.17 EPS. Encompass Health’s quarterly revenue was up 9.9% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, equities analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be issued a dividend of $0.19 per share. The ex-dividend date is Wednesday, April 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is currently 13.72%.

Insider Buying and Selling

In other Encompass Health news, CEO Mark J. Tarr sold 150,000 shares of the company’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the transaction, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. This represents a 28.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 2.00% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.